Targeting GLI1 in Inflammatory Breast Cancer
Author Information
Author(s): Thomas Z I, Gibson W, Sexton J Z, Aird K M, Ingram S M, Aldrich A, Lyerly H K, Devi G R, Williams K P
Primary Institution: Biomanufacturing Research Institute and Technology Enterprise (BRITE), Durham, North Carolina Central University, Durham, NC, USA
Hypothesis
Does targeting GLI1 expression in inflammatory breast cancer cells enhance apoptosis and reduce migration?
Conclusion
Targeting GLI1 in inflammatory breast cancer cells reduces cell proliferation, increases apoptosis, and inhibits migration.
Supporting Evidence
- GLI1 expression was significantly higher in SUM149 and rSUM149 cells compared to other breast cancer cell lines.
- Downregulation of GLI1 led to a 46-50% decrease in cell proliferation.
- GLI1 silencing resulted in a 3.2-fold increase in apoptotic cells.
- Silencing GLI1 significantly reduced the migration ability of SUM149 and rSUM149 cells.
Takeaway
Scientists found that lowering a protein called GLI1 in certain breast cancer cells helps the cells die and stop moving around.
Methodology
The study used immunoblots, MTT assays, Annexin-V/PI assays, and cell migration assays to assess the effects of GLI1 suppression.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website